{
  "id": "e0a4fff1f58fa61c",
  "title": "Insmed Maps Aggressive 2026 : New Lung Disease Drug , Pipeline Advances - Insmed ( NASDAQ : INSM ) ",
  "description": "20260109T164500Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/markets/guidance/26/01/49815983/insmed-maps-aggressive-2026-as-newly-approved-lung-disease-drug-gains-traction-pipeline-advances",
  "published_at": "20260109T164500Z",
  "fetched_at": "2026-01-10T00:22:56.872596+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/markets/guidance/26/01/49815983/insmed-maps-aggressive-2026-as-newly-approved-lung-disease-drug-gains-traction-pipeline-advances",
    "url_mobile": "",
    "title": "Insmed Maps Aggressive 2026 : New Lung Disease Drug , Pipeline Advances - Insmed ( NASDAQ : INSM ) ",
    "seendate": "20260109T164500Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2026/01/09/Konskie--Poland---December-08--2024-Insm.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}